Adding high added value in formulation design! It is applied to investigational drugs targeting compounds in the development stage.
The physical properties of active pharmaceutical ingredients often pose significant challenges in the formulation design of solid dosage forms. The "dry particle coating technology" masks the shortcomings of active pharmaceutical ingredients and adds high value in formulation design. It has various advantages over wet particle coating processes. Additionally, under solvent-free drying conditions, small particles are covered on the surfaces of larger particles by applying significant energy, such as impact and shear stress. By applying further force, the small particles fuse with the larger particles. We have successfully developed formulations using this technology and are applying it to investigational drugs targeting compounds in the development stage. 【Advantages】 ■ Cost-effective manufacturing ■ Formulation of active pharmaceutical ingredients that are unstable in water and heat ■ High-dose formulations/small tablets ■ Masking of odors/tastes *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog(1)
Download All CatalogsCompany information
Our company is a pharmaceutical CMC research and development contract company that spun out from the CMC research division of Takeda Pharmaceutical Company Limited in July 2017. We support excellent pharmaceutical development as experts in CMC research. Our research team consists of experts with extensive experience and achievements in process chemistry, formulation research and development, and analytical testing development related to CMC research. We provide high-level services and solutions tailored to our customers' needs across each process from the early stages of pharmaceutical development to application, while flexibly collaborating. We have established a collaborative system with partner companies, enabling us to offer a one-stop service. Please utilize us as a platform for your pharmaceutical development.